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SUMMARY 
36 subjects were included in a study on the efficacy of EMC biofeedback training in the management of anxiety 
neurosis. The outcome measures included a physiological stress profile and measures of anxiety symptoms, frontalis 
muscle tension, skin temperature and electrodermal activity. The data analysis indicated that the subjects were able to 
maintain reduced levels of frontalis muscle tension at rest and during the stress condition without concomitant changes 
in skin temperature or in electrodermal activity. This pattern of results supported the prediction of the motor skills 
learning model of EMG biofeedback. The clinical benefits of the training were manifested in the decreased anxiety 
symptom scores. 
EMG biofeedback as a relaxation tech-
nique is the logical outcome- of research 
evidence that biofeedback techniques can 
effectively modify autonomic nervous sys-
tem and other bodily responses typically 
associated with anxiety states (Miller, 
1909). 
As the sole method of treatment EMG 
biofeedback is moderately efficacious while 
in comparison to other relaxation proce-
dures it may/may not be as effective or to 
have a singular advantage. In combination 
with other techniques its effects may be 
additive, non-contributory or unique 
(Quails and Sheehan, 1981; Tarler Benlolo, 
1978). The evidence does not convincingly 
demonstrate the specific value of frontalis 
EMG training with anxiety disorders (Rice 
and Blanchard, 1982) largely because of the 
methodological deficiencies in the existing 
research (Kewman and Roberts, 1983). 
A proper evaluation of treatment effec-
tiveness would require the use of a parti-
cular modality of feedback for the treatment 
of a particular disorder, in a particular 
patient population. Trained therapists 
would need to administer the treatment for a 
sufficient length of time, atleast 8-25 hours, 
with the goal of achieving a certain criterion 
level of the response (Steiner k Dinte, 
1981). 
Keeping in view the inconclusive evi-
deuce and the paucity of research on bio-
feedback in India, the authors sought to 
evaluate the efficacy of EMG biofeedback 
therapy in anxiety neurosis, using the treat-
ment package strategy (Kazdin, 1980). 
Material and Methods 
Sample: 
Subjects with anxiety symptoms were 
referred to the Behaviour Therapy and Bio-
feedback Unit, Department of Clinical Psy-
chology at the National Institute of Mental 
Health and Neuro Sciences (NIMHANS), 
from the Psychiatry Out-patient centers of 
NIMHANS and Victoria Hospital, 
Bangalore. 36 subjects with a diagnosis of 
anxiety neurosis (300.0. ICD-9, 1978), 
completed the twenty-session EMG 
biofeedback therapy program. They were 
literate, without an associated medical 
illness or an additional/alternative psy-
chiatric diagnosis. 
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Assessment Measures: 
(a) Psychological : — 
State trait Anxiety Inventory- Form Yl 
(STAI-Y1) (Spielberger et al., 1983). 
Symptom Rating Scale (SRS) (Sargtmaraj 
and Kumaraiah, 1989). 
Hamilton's Anxiety Rating Scale (HARS) 
(Hamilton, 1959; Lader and Marks, 1971). 
(b) Physiological :— 
Feedback myograph (Instruction 
manual, Autogen 1700). 
Feedback thermometer (Instruction 
manual, Autogen 2000 b), 
Feedback dermograph (Instruction 
manual, Autogen 3400). 
Physiological stress profile (Budzynski 
et al., 1980). 
Following a 5 minutes adaptation 
period, the therapist recorded the levels of 
frontalis muscle tension (EMG), skin tem-
perature (TEMP), skin conductance level 
(SCL) and response (SCR) during the 14 min 
of relaxation, 6 min of stress (substracting 
serial sevens from 700) and 10 min of 
recovery. 
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Procedure: 
Each subject was assessed prior to the 
intervention (pre-therapy), after the initial 
ten training sessions (mid-therapy), and 
after the next ten training sessions (post-
therapy) with the STAI-Y1, SRS & HARS. 
Following a 5 minutes adaptation period, 
the therapist recorded resting levels of 
EMG, TEMP, SCL and SCR at 50 seconds 
intervals during the 30 minutes sessions. 
The physiological stress profile was assessed 
before and after the therapy program. 
The EMG biofeedback therapy program 
was designed to teach the subject awareness 
and control of frontalis muscle tension and 
generalisation of tension reduction. The 
program was flexible enough to allow for 
individual differences in learning but at the 
end of 20 sessions all subjects had passed 
through the three stages. 
At the post-therapy clinical interview, 
each subjects was interviewed to ascertain 
whether alternate treatments had been uti-
lised during this period. Following this each 
subject was advised to continue the practice 
of relaxation at home and to return to the 
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Results 
Preliminary analysis ;— 
12 subjects stated that they had used 
chemotherapy (betablockers/benzodia-
zepines/antidepressants) as a treatment 
adjunct. 
To determine whether this had influ-
enced the outcome measures, the sample of 
subjects with and without medication was 
compared using an analysis of covariance 
(ANCOVA) (Garrett, 1981) 
As shown in Table I, the non-significant 
F values indicate that the pre-therapy diffe-
rences within the sample did not influence 
the post-therapy values. 
Pre, mid and post-therapy comparison 
of the psychological and physiological asse-
ssment measures: 
Each clients' score on the STAI-Form Yl, 
the SRS and the HARS, was used to calculate 
average values for the group on the res-
pective measures. The frontalis muscle 
tension values recorded during the pre-
therapy assessment session were averaged 
for each subject and across subjects to 
provide a group mean value. Similarly, 
group mean values were obtained for the 
mid-and post-therapy assessment intervals. 
The data on skin temperature, skin con-
ductance level and response were treated in 
Table! Pre- and Post- Therapy assessment means andF values 
for Group I (EMG Feedback alone) and Group II 
(EMG Feedback plus Medication) 
Variables 
STAI-Y1 
SRS 
HARS 
EMG 
TEMP 
SCL 
SCR 
II 
I 
II 
I 
II 
I 
II 
I 
II 
I 
H 
I 
II 
Pre-therapy Post-therapy Corrected 
Means Means Means 
43.71 
48.50 
427.33 
343.08 
333.25 
377.50 
2.18 
3.24 
90.99 
91.17 
23.29 
21.91 
0.19 
0.19 
32.38 
35.42 
263.79 
159.17 
102.88 
83.00 
1.36 
1.38 
90.05 
89.78 
19.11 
16.41 
0.19 
0.30 
33.32 
34.49 
235.99 
186.98 
110.40 
75.48 
1.43 
1.31 
90.10 
89.73 
18.84 
16.68 
0.19 
0.30 
0.16 
1.35 
1.56 
0.33 
0.05 
0.15 
0.75 
Table-II Group Mean Values and F Ratios for the Psychological and Physiological Variables Across Assessments 
STAI-Y1 
SRS 
HARS 
EMG 
TEMP 
SCL 
SCR 
Pre 
Mean 
45.31 
399.25 
348.00 
2.53 
91.05 
22.83 
0.19 
-therapy 
S.D. 
11.82 
257.69 
152.22 
1.48 
5.13 
20.31 
0.50 
Mid 
Mean 
38.81 
264.86 
169.47 
1.56 
90.03 
17.08 
0.36 
-therapy 
S.D. 
10.27 
215.74 
118.75 
0.68 
5.51 
12.66 
0.42 
Post 
Mean 
33.39 
228.92 
96.25 
1.37 
89.96 
18.21 
0.22 
-therapy 
S.D. 
8.97 
208.26 
91.46 
0.58 
5.07 
17.28 
0.33 
F(2, 70) 
27.29* 
39.42 
99.72 
20.75 
1.19 
2.19 
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the same manner. Table II indicates the 
group mean values and the F ratios ohtuincd 
on all the measures using the repeated 
measures analysis of variance (ANOVA-R) 
(Winer, 1971). 
The change across the three assessments 
was significantly linear for state anxiety (F = 
54.43. p <.01), self-re]K>rt of symptoms (F = 
70.94, p<.01), therapist's rating (F = 188.45, 
p<.01) and frontalis muscle ten- sion (F = 
36.16, p <.01) while the change was not signi-
ficant for skin temperature (F = 1.89, NS), 
skin conductance level (F = 2.52, NS) and 
response(F = 0.12, NS). 
Pre-and post-therapy comparison of the 
physiological stress profile: 
On each physiological variable, for each 
subject for the phases of relaxation, stress 
and recovery, a mean value was calculated 
for each phase. The mean values of each 
phase were averaged across clients to pro-
vide group mean values. 
The pre-and post-therapy group mean 
values on each variable were compared with 
ANCOVA. The data is peresented in Table 
III. 
During the pre-therapy stress phase 
clients manifest an increase in muscle ten-
sion, skin conductance level and response 
and a reduction in temperature indicating 
that the cognitive task was adequately 
stressful. 
After therapy, there was a significant 
change in the frontalis muscle tension valu-
es from the relaxation to the stress phases (t 
= 4.6, p <.01) and from the stress to the 
recovery phases (t = 3.1, p<.01). The 
change from the relaxation to the recovery 
phase was non-significant (t = 1.5, NS). 
The clients hence manifest a lower base-
line KMG, a diminished reactivity to stress 
and a recovery to baseline EMG levels. The 
changes in skin temperature, skin conduc-
tance level and response were not signi-
ficant. 
Discussion 
It is possible that the use of pharma-
cological substances could complicate the 
learning of physiological self-regulation 
either by artificially altering natural base-
lines or by interfering with the normal 
range of a particular response system or by 
Table HI Pre-Post comparison on the Phvsiological Stress Profile 
KMG 
TKMP 
SC.L 
SCR 
Pre-' 
Relaxation 
2.52 
90.91 
22.71 
0.18 
Tierapy 
Stress 
2.88 
89.88 
33.69 
0.61 
Recovery 
2.'* 
90.08 
31.39 
-0.4!) 
Post-Therapy 
Relaxation 
1.32 
90.14 
19.64 
0.19 
Stress 
2.24 
89.8!! 
23.65 
0.65 
Re rovery 
1.62 
89.52 
24.40 
0.21 
K(2,104) 
10.79* 
0.12 
1.22 
1.68 
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fostering learning of self-regulation that 
does not generalise to a drug-free state (De 
Good tc Mohr, 1984). The present findings 
indicate that medication usage did not sig-
nificatly influence the |K>st-therapy values. 
The subjects were able to maintain lowe-
red levels of EMG activity at rest during the 
mid-and jxwt-thcrapy assessment sessions. 
The linear decrease in KMG levels was not 
accompanied by concomitant -changes in 
skin temperature, skin conductance level 
and response. This is consistent with the 
research indicating that the effect of KMG 
biofeedback training is remarkably specific 
with limited crossmodality generalisation 
effects (Carlson et al., 198.1)! 
The specificity of the training effect was 
reflected in the pre-post therapy changes on 
the physiological stress profile. A finding 
which conforms to the results reported in 
the literature (Diaz and Carlson, 1984). 
This pattern of results concurs with the 
prediction from the motor skills learning 
model (Alexander, 1975; Fridlund et al., 
1980) that biofeedback reinforces discri-
minative responding to produce "muscular 
change of a highly specific nature" (Glaus & 
Kotses, 1979). This specificity has been 
observed in the earlier studies by the 
authors (Sargunaraj et al., 1987, a k b). 
The reduction in frontalis muscle 
tension was accompanied by a reduction in 
state anxiety. This implies that KMG 
biofeedback therapy is associated with 
changes in the subjects ''subjective con-
sciously perceived feelings of tension, 
apprehension, nervousness and worry" 
(Spiel Ix-rger, 1985). 
Further, the linear decrease in anxiety 
svmptom scores as rated by the client and 
the therapist are indicative of the clinical 
benefits of KMG biofeedback training. 
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